APC.H — Advanced Proteome Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
Annual cashflow statement for Advanced Proteome Therapeutics, fiscal year end - July 31st, USD millions except per share, conversion factor applied.
2018 July 31st | 2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.893 | -0.461 | -0.541 | -1.92 | 0.597 |
| Depreciation | |||||
| Non-Cash Items | -0.194 | -0.39 | 0.001 | 1.39 | -1.57 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.131 | 0.161 | 0.07 | -0.013 | 0.278 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -1.21 | -0.686 | -0.467 | -0.545 | -0.694 |
| Capital Expenditures | — | -0.001 | 0 | -0.002 | -0.014 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -0.048 | 0 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -0.001 | 0 | -0.05 | -0.014 |
| Financing Cash Flow Items | — | — | — | — | 0.279 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.21 | 0.683 | 0.337 | 1.42 | 0.429 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.002 | -0.004 | -0.13 | 0.82 | -0.278 |